Mednovation inks cooperation agreement with Life Science Intelligence to support innovation in Chinese Medtech market

Mednovation has entered into a cooperation agreement with Life Science Intelligence, Inc. (LSI) to promote the parties to the Medtech industry worldwide, and to cooperate with each other to support development and innovation in the Chinese Medtech market. Under the agreed arrangement, which is effective as of this release, Mednovation shall be the preferred partner of LSI for its partnering events, seminars, market intelligence products, research services and other initiatives in China. Mednovation will support LSI for its major conferences in overseas countries, such as the 2023 LSI Emerging Medtech Summit in Dana Point, California (LSI USA '23). The parties will also work together to expand LSI's ecosystem to include partnering events curated and hosted specifically for Asian markets, including China. William Jin, partner of Mednovation, said: "We are happy to build up a strategic relation with LSI. I believe the cooperation between the two parties will greatly help us and the members of Mednovation to access international markets and resources. We can also help LSI to further explore the Chinese market." Scott Pantel, CEO of LSI, said: China's ecosystem presents a tremendous opportunity to advance Medtech innovation and continue our efforts towards saving patient lives and improving the standard of care globally. With our industry partnering events and market intelligence services, we support Medtech leaders in global markets. We are excited to take another step in advancing our global reach as we begin our transformative entry into China and engage their active Medtech innovation ecosystem." The Mednovation is a platform of industrial leaders, investors, and service providers of the Chinese Medtech industry. The company assist Medtech innovators seeking investors and collaboration opportunities in China market. LSI, the Medtech Market Intelligence company, helps Medtech leaders build businesses that save lives. With LSI's ecosystem of partnering events, market research products, and media services, Medtech businesses can access the community, capital, and insights that enable growth.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!